|
|

|
|
Title:
Removal of heparin from heparin-containing blood plasma samples using a triethylaminoethyl cellulose tablet
Abstract:
A tableted form of fibrous triethylaminoethyl cellulose suitable for the removal of heparin from heparin-containing blood plasma. The tablet is composed of granular microcrystalline cellulose and fibrous triethylaminoethyl cellulose in a ratio of from about 5.4:1 to about 10:1. The triethylaminoethyl cellulose tablet, which is formulated to provide from about 5 to about 26 mg. of triethylaminoethyl cellulose per milliliter of plasma sample, is added to a heparin-containing blood plasma sample, the sample is agitated or allowed to stand for a time sufficient to permit adsorption of substantially all heparin present. The sample is then centrifuged and the remaining heparin-free plasma can be subjected to coagulation testing in order to determine the true clotting time.
Do you think this is a good invention? Vote now:
Votes so far: For:(0) Against:(0) Other info:
Inventors:
Butler, James R. (Morris Plains, NJ, US) Turner, James E. (Morristown, NJ, US) Goodhart, Frank W. (Morristown, NJ, US)
Application Number:
050355
Filing Date: 1979-06-20 Publication_date: 1980-10-07 Assignee:
Warner-Lambert Company (Morris Plains, NJ)
Primary Class(es):
436/175
536/21
Other Classes:
US Patent Ref:
Other Refs:
Other References:
Chemical Abstracts, 78:112325b (1973). Nealon et al., "An Extracorporeal Device to Treat Barbiturate Poisoning," JAMA, Jul. 1966, vol. 197, No. 2, 158-160. Thompson et al., "Removal of Heparin and Protamine from Plasma," J. Lab. Clin. Med., 88, 922-929 (Dec. 1976). |